TomoTherapy Receives FDA 510(k) Clearance For TomoDirect? Radiotherapy Technology
TomoTherapy Incorporated (NASDAQ: TOMO) announced that it has received FDA 510(k) clearance for its TomoDirect? radiation therapy technology. TomoDirect is an innovative new discrete-angle, sliding-beam delivery mode for the Hiâ?¢Art® treatment system.
More: continued here
Filed under: Radiology on September 8th, 2008